Dr. Sergey Arutyunyan, DO

Dr. Arutyunyan practices at Visage Dermatology in Saint Petersburg, Florida.

Dr. Arutyunyan's NPI, 1295274843, was assigned on February 15, 2017. Dr. Arutyunyan graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2017. Dr. Arutyunyan holds Florida license OS15519.

Dr. Arutyunyan's primary practice is Visage Dermatology, at 5253 Central Ave, Saint Petersburg, FL 33710-8141. The practice phone is (727) 388-6982.

Dr. Arutyunyan's primary practice is Visage Dermatology in Saint Petersburg, Florida. The medical group on file is Visage Dermatology. Dmand AI also links Dr. Arutyunyan to 2 more group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arutyunyan practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Arutyunyan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Arutyunyan is board certified in dermatology by the American Board of Dermatology. Dr. Arutyunyan is licensed in Florida.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, rash, scalp rash and skin cyst among the conditions Dr. Arutyunyan treats.

CMS data shows 1,938 Medicare services from Dr. Arutyunyan across 25 procedure codes in 2024, for 308 Medicare patients. Medicare paid $313,695 for them. Every service was in an office.

CMS counts 308 Medicare patients who saw Dr. Arutyunyan in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Arutyunyan's median patient age at 73, with 48% women.

In 2024, Dr. Arutyunyan wrote 316 Medicare Part D claims for 208 patients. 100% of them were for generic drugs. CMS names the drug for 284 of them, across 9 drugs with 11 or more claims each, at $3,330 in total drug cost. In 2023, CMS named 156 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Arutyunyan for performance year 2024, reported as part of a group. Dr. Arutyunyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 68 procedures of melanoma (skin cancer) excision by Dr. Arutyunyan, more than 89% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Arutyunyan, published from 2009 to 2022. 2010 was the busiest year, with 2. The most frequent topics are Peptides, Cyclic and Thiazoles. Dr. Arutyunyan has published most often in Bioorg Med Chem Lett. Dr. Arutyunyan's most frequent co-authors are Brandon Michael Basehore, DO, Ana M. Duarte, MD and John Charles Howard, DO.

CMS Open Payments shows 145 general payments to Dr. Arutyunyan from 20 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $2,531.

Dmand AI lists 9 awards for Dr. Arutyunyan, most recently 3rd Place Research Competition in 2022.

Dr. Arutyunyan graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2017. Dr. Arutyunyan is a member of AAD, AOA and ASDS.

Dr. Arutyunyan is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.